Osaic Holdings’s IO Biotech IOBT Stock Holding History

Osaic Holdings’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-230	Closed	-$242	–	7531
2024 Q3	$242	Buy	+230	New	+$290	﹤0.01%	7146

Other funds holding IOBT

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings's IOBT Position: Q4 2024 in Review

Osaic Holdings sold out of IO Biotech (IOBT) in Q4 2024, closing a stake of 230 shares — an estimated $242 sold.

Osaic Holdings first reported a position in IOBT in Q3 2024 and held it in 1 quarter. The position peaked at $242 in Q3 2024. 27 funds tracked by Wall St. Rank hold IOBT as of Q4 2024.

Osaic Holdings reported no remaining IO Biotech position as of Q4 2024 after selling out during the quarter.
Osaic Holdings sold 230 IO Biotech shares in Q4 2024, an estimated $242.
Osaic Holdings first reported a position in IO Biotech in Q3 2024 and held it in 1 quarter.
Osaic Holdings's IO Biotech position peaked at $242 in Q3 2024.
27 funds tracked by Wall St. Rank held IO Biotech as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.